Articles

Editor's Page

• Preserving the Culture of Innovation in Retina

  By Allen C. Ho, MD Chief Medical Editor; and Robert L. Avery, MD Associate Medical Editor

Business of Retina

• Clinical Trials for the Retina Specialist

  The Renaissance of Drug Delivery Systems for the Posterior Segment

  By ARON SHAPIRO; AND ELIOT LAZAR, MD

• Fellows' Focus

  Clinical Trials: The Basics of Operation and Participation

  By ANDRE J. WITKIN, MD; NIKOLAS J.S. LONDON, MD; AND ALOK S. BANSAL, MD; WITH CARL D. REGILLO, MD, FACS; JOEL A. PEARLMAN, MD, PHD; AND DAVID S. BOYER, MD

• Retina in the ASC

  Considerations When Choosing an EHR System

  By ARUN KAPUR

Retina Surgery

• Retina Pearls: Managing Proliferative Vitreoretinopathy With Retinal Detachment

  There is a high probability of anatomic success after repair.

  By TAREK S. HASSAN, MD

• Global Perspectives: Microincisional Vitrectomy Surgery in Japan: An Update

  By YUICHIRO OGURA, MD

• Surgicial updates: The Silicone Sandwich Technique

  By MARK S. MANDELCORN, MD FRSCS; EFREM D. MANDELCORN, MD FRCSC; ANDRES EMANUELLI, MD; AND THOMAS A. ALBINI, MD

Oncology

• Case Reports in Ocular Oncology: Combined Hamartoma of the Retina and Retinal Pigment Epithelium with Poor Visual Acuity BY

  By NICOLE C. BEHARRY, MD; KIRAN TURAKA, MD; AND CAROL L. SHIELDS, MD

Cover Stories

• The Evolution of Retinal Gene Therapy: From DNA to FDA

  JEAN BENNETT, MD, PHD; AND ALBERT M. MAGUIRE, MD

• Human Adult Umbilical Stem Cells: Potential Treatment for Atrophic AMD

  A phase 1 clinical trial is assessing safety.

  By ALLEN C. HO, MD

• Update on Laser Plus Intravitreal Ranibizumab for Diabetic Macular Edema

  Two-year results of a clinical trial show continued efficacy.

  By THOMAS W. STONE, MD; AND TIM DONALD, ELS

• Anti-VEGF Treatment for Diabetic Macular Edema

  Aggressive treatment helped to control DME in the third year of follow-up in the READ-2 study.

  By THOMAS G. CHU, MD, PHD

• Emerging Treatments for Dry AMD

  A number of early clinical trials are under way.

  By DAVID S. BOYER, MD

• Clinical Implications of Potential Therapies for Diabetic Macular Edema

  Several therapies have been investigated or are in use; none are approved specifically for DME.

  By QUAN DONG NGUYEN, MD, MSC; DIANA V. DO, MD; DAVID S. BOYER, MD; AND JULIA A. HALLER, MD

• Genetic Basis of Age-related Macular Degeneration

  The Haplotype Map has elucidated the complex and polygenic basis of AMD.

  By JACLYN L. KOVACH, MD

• Electrical Stimulation Therapy for Retinal Degeneration

  Initial reactions from patients indicate major interest in this mode of therapy.

  By WALTER G. WROBEL, MD, PHD; GUIDO BLAESS, PHD; CARMEN EIPPER; ALEX HARSCHER, PHD; AND ANUSCH HEKMAT, PHD

Retina Surgery

• New Parameters in Vitreoretinal Surgery

  Safer intraoperative IOP regulation may help to avoid iatrogenic injury.

  By PRAVIN U. DUGEL, MD; AND DAVID BUBOLTZ, BS, MBA

• Posterior Scleral Buckle for Posterior Perforating Eye Injuries

  Use of radial elements for these injuries reduced rates of retinal detachment.

  By KRISTINE K. PIERCE, MD; AND R. GARY LANE, MD

• Vitreoretinal Surgery in Anticoagulated Patients

  Vitreoretinal surgery can be safely performed while maintaining warfarin anticoagulation in many patients.

  By M. GILBERT GRAND, MD

Retinal Imaging

• Advanced Imaging Technology Enhances Pediatric Ophthalmology Practice

  SD-OCT case reports.

  By STEPHEN B. PREPAS, MD

Retina Business

• Cooperative Competitiveness in a Multi-Practice Office- Surgery Complex

  A downtown center offers synergy, efficiency.

  By E. MITCHEL OPREMCAK, MD

• 5 Q With Diana V. Do, MD

  Dr. Do is an Associate Professor of Ophthalmology and Assistant Head of the Retina Fellowship Training Program at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, in Baltimore, Maryland.

View All News >